Between Aug. 12-13, 2014, a total of 152 new cases of Ebola virus disease (laboratory-confirmed, probable, and suspect cases) as well as 76 deaths were reported from Guinea, Liberia, Nigeria and Sierra Leone.
Some airlines and social media and traditional media vehicles expressed concern that air travel to and from affected countries was a high-risk activity for the spread of Ebola. To correct this misunderstanding, the World Health Organization (WHO) called a press conference at the UN Palais des Nations in Geneva on Aug. 14, 2014. Dr. Isabelle Nuttall, speaking on behalf of WHO, said, “Air travel, even from Ebola-affected countries, is low-risk for Ebola transmission.”
Nuttall further clarified modes of transmission for Ebola and emphasized that the disease is not an airborne virus, unlike influenza or tuberculosis. The infection is transmitted to others through direct contact with the bodily fluids of a sick person, such as blood, vomit, sweat, and diarrhoea. Even if an individual infected with EVD travels by plane, the likelihood of other passengers and crew coming into contact with the individual’s bodily fluids is very low.
WHO does not recommend any travel or trade restrictions be applied except in cases where individuals have been confirmed or are suspected of being infected with EVD or where individuals have had contact with cases of EVD. (Contacts do not include properly-protected health-care workers and laboratory staff.)
On Aug. 13, 2014, heads of Global Information Systems (GIS) for WHO, UN agencies, intergovernmental agencies, and partners met to continue mapping the EVD crisis and create an interagency common operations picture. This will allow WHO and other organizations responding to the crisis in the affected countries to pinpoint where personnel and material should be concentrated for an effective end to the outbreak.
Source: WHO
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.